Peter Blaney
Peter Blaney has broad spectrum experience as a biotechnology entrepreneur and investor. He has founded companies and led investments in a variety of biotechnology sectors including advanced medical diagnostics and drug delivery.
Nicol MacNicol
Nicol is a Portfolio Manager with expertise in biotech fundraising, valuation, and investor strategy. He has extensive experience leading capital formation and strategic partnerships. Nicol has been active with SignPost since inception.
LinkedIn https://www.linkedin.com/in/nicol-macnicol-49106619/
Jeb Connor
30+ years serial entrepreneur period as the founding executive, CEO, and/or Chairman of multiple investor backed software and technology companies in the biotech/diagnostics/tools, healthcare, and information technology markets, some ground floor start-ups, others as turnarounds, but all involving strategy development.
Rajen Dalal
Rajen is Founder/CEO at Continuum Care, a pre-seed stage, at-home digital health company. He has more than 30 years experience in creating and launching diagnostics. Rajen’s education includes a BSc in chemistry from St. Xavier in Bombay India, a MS in Biochemical Engineering from MIT and an MBA from the University of Chicago.
Lee McCracken
Lee is Chairman of Drawbridge Health, an innovative blood collection device company. He is former CEO of Nephrosant and has been CEO, COO, CBO in other biotech companies with substantial experience in diagnostics. He has an MBA from UCLA and an MS from the University of Dayton.
Ryan Smith
Ryan is President and CEO of Touchwood Properties Ltd and Smith Building & Development Ltd. Ryan is an invested partner in various business endeavors within the energy sector.
Wiliam J Kridel Jr.
At Ferghana Partners, responsible for new business development and for all types of transactions across all of the industry segments, as well as participating in the evaluation of science, technology and clinical development aspects of clients, counterparties and competitor companies.
LinkedIn https://www.linkedin.com/in/kridel/
Paul Lucas
With more than 20 years of leadership experience as President and CEO of GlaxoSmithKline Canada, Paul Lucas has significant expertise in the drug delivery and diagnostic health care space.
Barry Markowsky
Barry Markowsky served as vice-president of development for GlaxoSmithKline for more than 10 years. He has a talent for building innovative business models and solutions and creating start-ups in biotech and pharmaceuticals.
LinkedIn https://www.linkedin.com/in/barry-markowsky-56aa3234/
Edward Cho
Over 20 years of biomedical research experience with a focus on cancer biology and imaging. Currently Co-Founder and CSO at Spin Bio, developing a high-throughput single cell analysis platform, and also Head of Biologics Development at Detect.
LinkedIn https://www.linkedin.com/in/edcho/